Insider · CIK 0001376491
Philip Astley-Sparke
Files at REPL (Replimune Group, Inc.), ENGN (enGene Holdings Inc.). First filing May 22, 2025, latest May 22, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
REPL: Replimune Group, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Replimune Group, Inc. | $260k 32,279 shares | -2% | +33% from low-38% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2026 | REPL Replimune Group, Inc. | GGift Common Stock | -25,000 | $0.00 | $0 | 1,380,071 | Feb 20, 2026 |
| Jul 8, 2025 | ENGN enGene Holdings Inc. | AGrant or award Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 45,000 | Jul 10, 2025 |
| May 20, 2025 | REPL Replimune Group, Inc. | SOpen-market sale Common Stock | -32,279 | $8.06 | $260k | 1,405,071 | May 22, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.